HIV-1 hides an Achilles' heel in virion lipids
- PMID: 18199412
- PMCID: PMC2673567
- DOI: 10.1016/j.immuni.2007.12.005
HIV-1 hides an Achilles' heel in virion lipids
Abstract
In this issue, Sun et al. (2008) model the interface between a neutralizing antibody and HIV-1 glycoprotein 41 (gp41) envelope peptide in lipids. This model could help overcome a roadblock in HIV-1 vaccine development.
Figures
Comment on
-
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane.Immunity. 2008 Jan;28(1):52-63. doi: 10.1016/j.immuni.2007.11.018. Immunity. 2008. PMID: 18191596
Similar articles
-
Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.AIDS Res Hum Retroviruses. 1995 Jun;11(6):687-96. doi: 10.1089/aid.1995.11.687. AIDS Res Hum Retroviruses. 1995. PMID: 7576928
-
Formaldehyde-treated, heat-inactivated virions with increased human immunodeficiency virus type 1 env can be used to induce high-titer neutralizing antibody responses.J Virol. 2005 Aug;79(16):10210-7. doi: 10.1128/JVI.79.16.10210-10217.2005. J Virol. 2005. PMID: 16051814 Free PMC article.
-
Discrete partitioning of HIV-1 Env forms revealed by viral capture.Retrovirology. 2015 Sep 24;12:81. doi: 10.1186/s12977-015-0207-z. Retrovirology. 2015. PMID: 26399966 Free PMC article.
-
[The structure and virus-like particle vaccine of the HIV-1 capsid protein].Sheng Wu Gong Cheng Xue Bao. 2003 Sep;19(5):516-20. Sheng Wu Gong Cheng Xue Bao. 2003. PMID: 15969076 Review. Chinese.
-
HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.Mol Membr Biol. 2006 Nov-Dec;23(6):453-65. doi: 10.1080/09687860600935348. Mol Membr Biol. 2006. PMID: 17127618 Review.
Cited by
-
Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.Vaccine. 2009 Jul 23;27(34):4672-83. doi: 10.1016/j.vaccine.2009.05.059. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520200 Free PMC article.
-
Progress in HIV-1 vaccine development.J Allergy Clin Immunol. 2014 Jul;134(1):3-10; quiz 11. doi: 10.1016/j.jaci.2014.04.025. Epub 2014 Jun 26. J Allergy Clin Immunol. 2014. PMID: 25117798 Free PMC article. Review.
-
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.PLoS Pathog. 2011 Sep;7(9):e1002200. doi: 10.1371/journal.ppat.1002200. Epub 2011 Sep 1. PLoS Pathog. 2011. PMID: 21909262 Free PMC article.
-
High level of soluble HLA-G in the female genital tract of Beninese commercial sex workers is associated with HIV-1 infection.PLoS One. 2011;6(9):e25185. doi: 10.1371/journal.pone.0025185. Epub 2011 Sep 23. PLoS One. 2011. PMID: 21966450 Free PMC article.
-
Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.J Virol. 2009 Oct;83(19):10211-23. doi: 10.1128/JVI.00571-09. Epub 2009 Jul 29. J Virol. 2009. PMID: 19640992 Free PMC article.
References
-
- Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA. Immunity. 2005;22:163–173. - PubMed
-
- Eckert DM, Kim PS. Annu. Rev. Biochem. 2001;70:777–810. - PubMed
-
- Haynes BF, Fleming J, St Clair EW, Katinger H, Stiegler G, Kunert R, Robinson J, Scearce RM, Plonk K, Staats HF, et al. Science. 2005;308:1906–1908. - PubMed
-
- Haynes BF, Montefiori DC. Expert Rev. Vaccines. 2006;5:579–595. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources